Cell-cycle control and renal disease

Kidney International

Volumn 52, Issue 2, 1997, Pages 294-308

  Shankland, S J ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Cell cycle; Cyclin dependent kinases; Cyclin kinase inhibitors; Cyclins; Injury; Proliferation; Sclerosis

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; CYCLINE; RETINOBLASTOMA PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

APOPTOSIS; CELL CYCLE PHASE; CELL PROLIFERATION; DNA REPAIR; DNA SYNTHESIS; GLOMERULUS; GROWTH REGULATION; HUMAN; KIDNEY CELL; KIDNEY DISEASE; KIDNEY INTERSTITIUM; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0030751147     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.335     Document Type: Article

References (181)

1. L.J. Striker T. Doi S. Elliot G.E. Striker The contribution of glomerular cells to progressive glomerulosclerosis Semin Nephrol 9 1989 318 328
2. H.E. Abboud Growth factors in glomerulonephritis Kidney Int 43 1993 252 267
3. W.G. Couser R.J. Johnson Mechanisms of progressive renal disease in glomerulonephritis Am J Kid Dis 23 1994 193 198
4. R.B. Sterzel E. Schulze-Lohoff M. Marx Cytokines and mesangial cells Kidney Int 39 1993 26 31
5. R.J. Johnson E.W. Raines J. Floege A. Yoshimura P. Pritzl C. Alpers R. Ross Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor J Exp Med 175 1992 1413 1416
6. J. Floege M.W. Burns C.E. Alpers A. Yoshimura P. Pritzl K. Gordon R.A. Seifert D.F. Bowen-Pope W.G. Couser R.J. Johnson Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model Kidney Int 41 1992 297 309
7. B.A. Young R.J. Johnson C.E. Alpers E. Eng K. Gordon J. Floege W.G. Couser Cellular events in the evolution of experimental diabetic nephropathy Kidney Int 47 1995 935 944
8. V. Kliem R.J. Johnson C.E. Alpers A. Yoshimura W.G. Couser K.M. Koch J. Floege Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats Kidney Int 49 1996 666 678
9. R.B. Nagle M.R. Kneiser R.E. Bulger E.P. Benditt Induction of smooth muscle characteristics in renal interstitial fibroblasts during obstructive nephropathy Lab Invest 29 1974 422 427
10. G.L. Johnson R.R. Vaillancourt Sequential protein kinase reactions controlling cell growth and differentiation Curr Opin Cell Biol 6 1994 230 238
11. A.B. Pardee G1 events and regulation of cell proliferation Science 246 1989 603 608
12. C. Norbury P. Nurse Animal cell cycles and their control Annu Rev Biochem 61 1992 441 471
13. A. Zetterberg O. Larson K.G. Wiman What is the restriction point Curr Opin Cell Biol 7 1995 835 842
14. A. Murray T. Hunt The Cell Cycle 1993 W.H. Freeman and Co. New York
15. D.O. Morgan Principles of CDK regulation Nature 374 1995 131 134
16. C.J. Sherr J.M. Roberts Inhibitors of mammalian G1 cyclin-dependent kinases Genes Develop 9 1995 1149 1163
17. D. Hockenbery Defining apoptosis Am J Pathol 146 1995 16 19
18. W. Meikrantz R. Schegal Apoptosis and the cell cycle J Cell Biochem 58 1995 160 174
19. J.R. Smith O.M. Pereira-Smith Replicative senescence: Implications for in vivo aging and tumor suppression Science 273 1996 63 67
20. R.A. Weinberg HOW cancer arises Sci Am Sept 1996 62 70
21. K. Takase N. Terada J.J. Lucas E.W. Gelfand Control of cell cycle entry and progression in mitogen-stimulated human B lymphocytes J Cell Physiol 162 1995 246 255
22. E. Lees Cyclin dependent kinase regulation Curr Opin Cell Biol 7 1995 773 780
23. B. Herber M. Truss M. Beato R. Muller Inducible regulatory elements in the human cyclin Dl promoter Oncogene 9 1994 2105 2107
24. A.R. Brooks D. Shiffman C.S. Chan E.E. Brooks P.G. Milner Functional analysis of the human cyclin D2 and cyclin D3 promoters J Biol Chem 271 1996 9090 9099
25. B. Henglein X. Chenivesse J. Wang D. Eick C. Brechot Structure and cell cycle-regulated transcription of the human cyclin A gene Proc NatlAcad Sci USA 91 1994 5490 5494
26. J. Pines Cyclins and cyclin-dependent kinases: A biochemical view Biochem J 308 1995 697 711
27. K. Polyak J. Kato M.J. Solomon C.J. Sherr J. Massague J.M. Roberts A. Koff p27 kip1, a cyclin-Cdk inhibitor, links transforming growth factor- β and contact inhibition to cell cycle arrest Genes Develop 8 1994 9 22
28. M.-H. Lee I. Reynisdottir J. Masague Cloning of p57Kip2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution Genes Develop 9 1995 639 649
29. INK4b is a potential effector of TGF- β induced cell cycle arrest Nature 371 1994 257 261
30. M. Serrano G.J. Hannon D. Beach A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4 Nature 366 1993 704 707
31. F.K.M. Chan J. Zhang L. Cheng D.N. Shapiro A. Winoto Identifiation of human and mouse p19, a novel CDK4and CDK6 inhibitor with homology to p16 INK4 Mol Cell Biol 15 1995 2682 2688
32. H. Kobayashi E. Stewart R. Poon J.P. Adamczewski J. Gannon T. Hunt Identification of the domains in cyclin A required for binding to and activiation of, p34cdc2 and p32cdk2 protein kinase subunits Mol Biol Cell 3 1992 1279 1294
33. C.J. Sherr Mammalian G1 cyclins Cell 73 1993 1059 1065
34. In) function in yeast Cell 66 1991 1197 1206
35. J. Kato C.J. Sherr Inhibition of granulocyte differentiation by G1 cyclins D2 and D3 but not D1 Proc Natl Acad Sci USA 90 1993 11513 11517
36. M.E. Ewen H.K. Sluss C.J. Sherr H. Matsushime J. Kato D.M. Livingston Functional interactions of the retinoblastoma protein with mammalian D-type cyclins Cell 73 1993 487 497
37. J. Kato H. Matsushime S.W. Hiebert M.E. Ewen C.J. Sherr Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4 Genes Develop 7 1993 331 342
38. Y. Xiong H. Zhang D. Beach D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA Cell 71 1992 505 514
39. A. Sewing C. Burger S. Brusselbach C. Schalk F.C. Lubibello R. Muller Human cyclin Dl encodes a labile nuclear protein whose synthesis is directly induced by growth factors and suppressed by cAMP J Cell Sci 104 1993 545 554
40. K. Won Y. Xiong D. Beach M.Z. Gilman Growth-regulated expression of D-type cyclin genes in human diploid fibroblasts Proc Natl Acad Sci USA 89 1992 9910 9914
41. Y. Geng R.A. Weinberg Transforming growth factor β effects on expression of G1 cyclins and cyclin-dependent kinases Proc Natl Acad Sci USA 90 1993 10315 10319
42. V. Baldin J. Lukas M.J. Marcote M. Pagano G. Draetta Cyclin D1 is a protein required for cell cycle progression in G1 Genes Develop 7 1993 812 821
43. M. Pagano R. Pepperkok J. Lukas V. Baldin W. Ansorge J. Bartek G. Draetta Regulation of the cell cycle by cdk2 protein kinase in cultured human fibroblasts J Cell Biol 121 1993 101 111
44. D.E. Quelle R.A. Ashmun S.A. Shurtleff J.-Y. Kato D. Bar-Sagi M.F. Roussel C.J. Sherr Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts Genes Develop 7 1993 1559 1571
45. H. Matsushime M.F. Roussel R.A. Ashmun C.J. Sherr Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle Cell 65 1992 701 713
46. M. Ohtsubo A.M. Theodoras J. Schumacher J.M. Roberts M. Pagano Human cyclin E, a nuclear protein essentail for the G1-to-S phase transition Mol Cell Biol 15 1995 2612 2624
47. J.G. Gong B. Ardelt F. Traganos Z. Darzynkiewicz Unscheduled expression of cyclin B1 and cyclin E in several leukemic and solid tumor cell lines Cancer Res 54 1994 4285 4288
48. M. Ohtsubo J.M. Roberts Cyclin-dependent regulation of G1 in mammalian fibroblasts Science 259 1993 1908 1912
49. A. Koff M. Ohtsuki K. Polyak J.M. Roberts J. Massague Negative regulation of G1 in mammalian cells: Inhibition of cyclin E-dependent kinase by TGF- β Science 260 1993 536 539
50. S.T. Eblen M.P. Fautsch R.J. Burnette P. Joshi E.B. Leof Cell cycle-dependent inhibition of p34cdc2 synthesis by transforming growth factor β 1 in cycling epithelial cells Cell Growth Differ 5 1994 109 116
51. S. Bates D. Parry L. Boetta K. Vousden C. Dickson C. Peters Absence of cyclin D/CDK4 complexes in cells lacking functional retinoblastoma protein Oncogene 9 1994 1633 1640
52. S. Rogers R. Wells M. Rechsteiner Amino acid sequences common to rapidly degraded proteins: The PEST hypothesis Science 234 1986 364 368
53. M. Pagano R. Pepperkok F. Verde W. Ansorge G. Draetta Cyclin A is required at two points in the human cell cycle EMBO J 11 1992 961 971
54. F. Girard U. Strausfeld A. Fernandez N. Lamb Cyclin A is required for the onset of DNA replication in mammalian fibroblasts Cell 67 1991 1169 1179
55. T.M. Guadagno M. Ohtsubo J.M. Roberts R.K. Assoian A link between cyclin A expression and adhesion-dependent cell cycle progression Science 262 1993 1572 1575
56. S.H. Devoto M. Mudryji J. Pines T. Hunter J.R. Nevins A cyclin A-protein kinase complex possesses sequence-specific DNA binding activity: p33cdk2 is a component of the E2F-Cyclin A complex Cell 68 1992 167 176
57. S. Shirodkar M. Ewen J.A. Decaprio L.D. Morgon J T. Chittenden The transcription factor E2F interacts with the retinoblastoma product and p107-cyclin A complex in a cell cycle-regulated manner Cell 68 1992 157 166
58. M. Yoshizumi C.-M. Hsieh F. Zhou J. Tsai C. Patterson M.A. Perella M. Lee The ATF site mediates downregulation of the cyclin A gene during contact inhibtion in vascular endothelial cells Mol Cell Biol 15 1995 3266 3272
59. K.B. Reddy B.A. Hocevar P.H. Howe Inhibition of G1 phase cyclin dependent kinases by transforming growth factor β 1 J Cell Biochem 56 1994 418 425
60. D.J. Satterwhite M.E. Aakre A.E. Gorska H.L. M Inhibition of cell growth by TGF β 1 is associated with inhibition of B-myb and cyclin A in both BALB/MK and Mv1Lu cells Cell Growth Diff 5 1994 789 799
61. X.H. Feng E.H. Filvaroff R. Derynck Transforming growth factor- β (TGF- β )-induced down-regulation of cyclin A expression requires a functional TGF- β receptor complex J Biol Chem 270 1995 24237 24245
62. T.R. Coleman W.G. Dunphy Cdc2 regulatory factors Curr Opin Cell Biol 6 1994 877 882
63. J. Pines T. Hunter Isolation of a human cyclin cDNA: Evidence for cyclin mRNA and protein regulation in cell cycle and for interaction with P34cdc2 Cell 58 1989 833 846
64. E. Stewart H. Kobayashi D. Harrison T. Hunt Destruction of Xenopus cyclins A, B2, but not B1, requires binding to p34cdc2 EMBO J 13 1994 584 594
65. M. Glotzer A.W. Murray M.W. K Cyclin is degraded by the ubiquitin pathway Nature 1349 1991 132 138
66. M.J. Solomon J.W. Harper J. Shuttleworth CAK, the p34cdc2 activation kinase, contains a protein identical or closely related to p40MO15 EMBO J 12 1993 3133 3142
67. H.L. Debondt J. Rosenblatt J. Jancarik H.D. Jons D.O. Morgon Crystal structure of cyclin dependent kinase 2 Nature 363 1993 595 602
68. E.M. Lees E. Harlow Sequences within the conserved cyclin box of human cyclin A are sufficient for binding to and activation of cdc2 kinase Mol Cell Biol 13 1993 1194 1210
69. T. Lorca J. Labbe A. Devalult Dephosphorylation of cdc2 on threonine-161 is required for cdc2 kinase inactivation and normal anaphase EMBO J 11 1992 2381 2390
70. B. Draetta cdc2 activation: The interplay of cyclin binding and Thrl61 phosphorylation Trend Cell Biol 3 1993 287 289
71. M. Meyerson E. Harlow Identification of Gl kinase activity for CDK6, a novel cyclin D partner Mol Cell Biol 14 1994 2077 2086
72. P. Nurse Universal control mechanism regulating onset of M-phase Nature 344 1990 503 508
73. M.E. Ewen H.K. Sluss L.L. Whitehouse D.M. Livingston TGF β inhibition of CDK4 synthesis is linked to cell cycle arrest Cell 74 1993 1009 1020
74. A.A. Russo P.D. Jeffrey A.K. Patten J. Massague N.P. Pavletich Crystal structure of the p27Kipl cyclin-dependent kinase inhibitor bound to the cyclin A-CDK2 complex Nature 382 1996 325 331
75. D. Shiffman E.E. Brooks A.R. Brooks C.S. Chan P.G. Milner Characterization of the human cyclin-dependent kinase 2 gene J Biol Chem 271 1996 12199 12204
76. H.R. Herschman Primary response genes induced by growth factors and tumor promoters Annu Rev Biochem 60 1991 281 319
77. E.A. Nigg Targets of cyclin-dependent kinases Curr Opin Cell Biol 5 1993 187 193
78. R.A. Weinberg The retinoblastoma protein and the cell cycle Cell 81 1995 323 330
79. M. Laiho J.A. Decaprio J.W. Ludlow D.M. Livingston J. Massague Growth inhibition by TGF- β linked to suppression of retinoblas toma protein phosphorylation Cell 62 1990 175 185
80. N.B. La Thangue DP and E2F proteins: Components of a het-erodimeric transcription factor implicated in cell cycle control Curr Opin Cell Biol 6 1994 443 450
81. J.R. Nevins E2F; A link between the Rb tumor suppressor protein and viral oncoproteins Science 258 1992 424 428
82. S.J. Elledge J.W. Harper CDK inhibitors: On the threshold of checkpoints and development Curr Opin Cell Biol 6 1994 847 852
83. M. Peter I. Herskowitz Joining the complex: Cyclin-dependent kinase inhibitory proteins and the cell cycle Cell 79 1994 181 184
84. K. Polyak M.-H. Lee H. Erdjument-Bromage A. Koff J.M. Roberts P. Tempst J. Massaue Cloning of p27Kip1, a cyclin-dependent inhibitor and a potential mediator of extracellular antimitogenic signals Cell 78 1994 59 66
85. C. Cordon-Cardo Mutation of cell cycle regulators. Biological and clinical implications for human neoplasia Am J Pathol 147 1995 545 560
86. W.S. El-Deiry T. Tokino V.E. Velculescu D.B. Levy R. Parsons J.M. Trent D. Lin W.E. Mercer K.W. Kinzler B. Vogelstein WAF1, a potential mediator of p53 tumor suppression Cell 75 1993 817 825
87. M.B. Datto J.F. Panus D.J. Howe Y. Xiong X.-F. Wang Transforming growth factor β induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism Proc Natl Acad Sci USA 92 1995 5545 5549
88. A. Elbendary A. Berchuck P. Davis L. Havrilesky R.C. Bast D. Iglehart J.R. Marks Transforming growth factor β 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells Cell Growth Diff 5 1994 1301 1307
89. P. Mazars N. Barboule V. Baldin S. Vidal B. Ducommun A. Valette Effects of TGF- β 1 on the cell cycle regulation of human breast adenocarcinoma (MCF-7) cells FEBS Lett 362 1995 295 300
90. C.-Y. Li L. Suardet J.B. Little Potential role of WAF1/Cip1/p21 as a mediator of TGF- β cytoinhibitory effect J Biol Chem 270 1995 4971 4974
91. S.B. Parker G. Eichele P. Zhang A. Rawls A.T. Sands A. Bradley E.N. Olson J.W. Harper S.J. Elledge p53-Independent expression of p21Cip1 in muscle and other terminally diffentiating cells Science 267 1995 1024 1027
92. R.A. Steinman B. Hoffman A. Iro C. Guillouf D.A. Lieberman M.E. El-Houseini Induction of p21 (WAF1/CIP1) during diffentiation Oncogene 9 1994 3389 3396
93. C. Missero E. Calautti R. Eckner J. Chin L.H. Tsai D.M. Livingston G.P. Dotto Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation Proc Natl Acad Sci USA 92 1995 5451 5455
94. Y.E. Chin M. Kitagawa W.-CS. Su Z.-H. You Y. Iwamoto Xi-Y Fu Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 Waf1/Cip1 mediated by STAT1 Science 272 1996 719 722
95. J. Nourse E. Firpo W.M. Flanagan S. Coats K. Polyak M. Lee J. Massague G.R. Crabtree J.M. Roberts Interleukin-2-mediated elimination of the p27 kip1 cyclin-dependent kinase inhibitor pre vented by rapamycin Nature 372 1994 570 573
96. J. Kato K. Matsuoka K. Polyak J. Massague C.J. Sherr Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase-4 activating kinase Cell 79 1994 487 496
97. T. Hirama H.P. Koeffler Role of cyclin dependent kinase inhibitors in the development of cancer Blood 86 1995 841 854
98. S.W. Tam J.W. Shay M. Pagano Differential expression and cell cycle regulation of the cyclin-dependent kinase 4 inhibitor p16INK4 Cancer Res 54 1994 5816 5820
99. K.-L. Guan C.W. Jenkins Y. Li M.A. Nichols X. Wu C.L. O'Keefe A.G. Matera Y. Xiong Growth suppression by p18, a p16INK4/MTS1 and p14INK4/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function Genes Develop 8 1994 2939 2952
100. J.W. Harper G.R. Adami N. Wei K. Keyomarsi J. Elledge The p21 cdk-interacting protein Cip1 is a potent inhibitor of Gl cyclin-dependent kinases Cell 75 1993 805 816
101. J.W. Harper S.J. Elledge K. Keyomarsi B. Dynlacht L. Tsai P. Zhang S. Dobrowolski C. Bai L. Connell-Crowley E. Swindell M.P. Fox N. Wei Inhibition of cyclin dependent kinases by p21 Mol Biol Cell 6 1995 387 400
102. S. Matsuoka M.C. Edwards C. Bai S. Parker P. Zhang A. Baldini J.W. Harper E. Sj p57Kip2, a structurally distinct member of the p21Cip1 CDK inhibitor family, is a candidate tumor suppressor gene Genes Develop 9 1995 650 662
103. O. Aprelikova Y. Xiong E.T. Liu Both p16 and p21 families of CDK inhibitors block CDK phosphorylation by the CDK activiating kinase (CAK) J Biol Chem 270 1995 18195 18197
104. I.T. Chen M. Akamatsu M.L. Smith F. Lung D. Duba P.P. Roleer A.J. Fornace Jr Charaterization of p21 Cip1/Waf1 peptide domains required for cyclin E/CDK2 and PCNA interaction Oncogene 12 1996 595 607
105. Y. Luo J. Hurwitz J. Massague Cell-cycle inhibition by independent CDK and PCNA binding domains in p21CIP1 Nature 375 1995 159 161
106. Y. Xiong G.J. Hannon G.J. Zhang D. Casso R. Kobayashi D. Beach p21 is a universal inhibitor of cyclin kinases Nature 366 1993 701 704
107. Y. Gu C.W. Turck D.O. Morgon Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit Nature 366 1993 707 710
108. A. Noda Y. Ning S.F. Venable O.M. Pereira-Smiths J.R. Smith Cloning of senescent cell-derived inhibitors of DNA synthesis using expression vectors Exp Cell Res 211 1994 90 98
109. R. Li S. Waga G.J. Hannon D. Beach B. Stillman Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair Nature 371 1994 534 537
110. J. Chen P.K. Jackson M.W. Kirschner A. Dutta Seperate domains of p21 involved in the inhibition of Cdk kinase and PCNA Nature 374 1995 386 388
111. G. Prelich C.K. Tan M. Kostura M.B. Mathews A.G. So K.M. Downey B. Stillman Functional identity of proliferating cell nuclear antigen and a DNA polymerase-d auxiliary protein Nature 326 1987 517 520
112. M.K.K. Shivji M.K. Kenny R.D. Wood Proliferating cell nuclear antigen is required for DNA excision repair Cell 69 1992 367 374
113. J. Chen R. Peters P. Saha P. Lee A. Theodoras M. Pagano G. Wagner A.A. Dutta 39 amino acid fragment of the cell cycle regulator p21 is sufficient to bind PCNA and partially inhibit DNA replication in vivo Nucl Acid Res 24 1996 1727 1733
114. S. Waga G.J. Hannon D. Beach B. Stillman The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA Nature 369 1994 574 578
115. M.W. Chang E. Barr M.M. Lu K. Barton J.M. Leidin Adenovirus-mediated over-expression of the cyclin/cyclin dependent kinase in hibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty J Clin Inveet 96 1995 2260 2268
116. V. Dulic W.K. Kaufmann S.J. Wilson T.D. Tisty E. Lees J.W. Harper S.J. Elledge S.I. Reed p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest Cell 76 1994 1013 1023
117. W.S. El-Deiry J.W. Harper P.M. O'Connor V.E. Velculescu C.E. Canman Jackmant J.A. Pietenpol M. Burrell D.E. Hill Y. Wang K.G. Wiman W.E. Mercer M.B. Kastan K.W. Kohn S.J. Elledge K.W. Kinzler B. Vogelstein WAF1/Cip1 is induced in p53 mediated G1 arrest and apoptosis Cancer Res 54 1994 1169 1174
118. O. Halevy B.G. Novitch D.B. Spicer S.X. Skapek J. Rhee G.J. Hannon D. Beach A.B. Lassar Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by myoD Science 267 1995 1018 1021
119. C. Deng P. Zhang J.W. Harper S.J. Elledge P. Leder Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control Cell 82 1995 675 684
120. J. Brugarolas C. Chandrasekaran J.I. Gordon D. Beach T. Jacks G.J. Hannon Radiation-induced cell cycle arrest comprimised by p21-deficiency Nature 377 1995 552 557
121. H. Wu M. Wade L. Krall J. Grisham V.D.T. Xiongy Y Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development, and regeneration Genes Develop 10 1996 245 260
122. H. Toyoshima T. Hunter p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21 Cell 78 1994 67 74
123. L. Hengst S.I. Reed Translational control of p27 accumulation during the cell cycle Science 271 1996 1861 1864
124. M. Pagano S.W. Tam A.M. Theodoras P. Beer-Romera G. Del Sal V. Chau P.R. Yew G.F. Draetta M. Rolfe Role of the ubiquitin-proteosome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27 Science 269 1995 682 685
125. S. Coats W.M. Flanagan J. Nourse J.M. Roberts Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle Science 272 1996 877 880
126. M.L. Fero M. Rivkin M. Tasch P. Porter C.E. Carow E. Firpo K. Polyak L. Tsai V. Broudy R.M. Perimutter K. Kaushansky J.M. Roberts A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27Kip1-deficient mice Cell 85 1996 733 744
127. H. Kiyokawa R.D. Kineman K.O. Manova-Todorova V.C. Soares E.S. Hoffman M. Ono D. Khanam A.C. Hayday L.A. Frohman A. Koff Enhanced growth in mice lacking the cyclin-dependent kinase inhibitor function of p27Kip1 Cell 85 1996 721 732
128. K. Nakayama N. Ishida M. Shirane A. Inomata T. Inoue N. Shishido I. Horii D.Y. Loh K. Nakayama Mice lacking p27Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors Cell 85 1996 707 720
129. H. Hirai M.F. Roussel J.-Y. Kato R.A. Ashmun S.C. Novel INK4 proteins. p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6 Mol CellBiol 12 1995 503 511
130. J. Marx New tumor suppressor may rival p53 Science 264 1994 344 345
131. S. Klahr G. Schreiner I. Ichikawa Progression in renal disease N Engl J Med 318 1988 1657 1666
132. J. Floege E. Eng B.A. Young W.G. Couser R.J. Johnson Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis Kidney Int 43 1993 369 380
133. Nt Fukui M I. Ebihara I. Nagaoka Y. Tomino Low-protein diet attenuates increased gene expression of platelet-derived growth factor and transforming growth factor- β in experimental glomerular scleosis J Lab Clin Med 121 1992 224 234
134. S. Okuda T. Nakamura T. Yamamoto E. Ruoslahti W.A. Border Dietery protein restriction rapidly reduces transforming growth factor β 1 expression in experimental glomerulonephritis Proc Natl Acad Sci USA 88 1991 9765 9769
135. J. Floege R.J. Johnson K.L. Gordon H. Iida P. Pritzl A. Yoshimura C. Campbell C.E. Alpers W.G. Couser Increased synthesis of extracellular matrix in mesangial proliferative nephritis Kidney Int 40 1991 477 488
136. J. Floege R.J. Johnson C.E. Alpers S. Fatemi-Nainie C.A. Richardson K. Gordon W.G. Couser Visceral glomerular epithelial cells can proliferate in vivo and synthesize platelet-derived growth factor p-chain Am J Pathol 142 1993 637 650
137. W. Kriz B. Hahnel S. Rosener M. Elger Long-term treatment of rats with FGF-2 results in focal segmental glomerulosclerosis Kidney Int 48 1995 1435 1450
138. K. Seyer-Hansen Renal hypertrophy in experimental diabetes mellitus Kidney Int 23 1983 643 646
139. L. Fine The biology of renal hypertrophy Kidney Int 29 1986 619 634 (Editorial Review)
140. S. Ishidoya J. Morrissey R. Mccracken A. Reyes S. Klahr Angiotensin II receptor antagonist ameliorates renal tubulointersti-tial flbosis caused by unilateral ureteral obstruction Kidney Int 47 1995 1285 1294
141. T. Yamada Y. Terada O. Nakashima S. Sasaki F. Marumo Regulation of G1 cyclin and cell cycle inhibitors in experimental glomerulonephritis J Am Soc Nephrol 7 1996 1726 (abstract)
142. S.J. Shankland C. Hugo S.R. Coats M. Nangaku R.H. Pichler K.L. Gordon J. Pippin J.M. Roberts W.G. Couser R.J. Johnson Changes in cell cycle protein expression during experimental mes angial proliferative glomerulonephritis Kidney Int 50 1996 1230 1239
143. S.J. Shankland J. Floege S.E. Thomas M. Nangaku C. Hugo J. Pippin K. Henne D.M. Hockenberry R.J. Johnson W.G. Couser Cyclin kinase inhibitors are increased during experimental membranous nephropathy: Potential role in limiting glomerular epithelial cell proliferation in vivo Kidney Int 52 1997 404 413
144. S.J. Shankland P.A. Hamel J.W. Scholey Cyclin and cyclin-dependent kinase expression in the glomeruli of normal, diabetic and renal-ablated rats J Am Soc Nephrol 5 1994 701 (abstract)
145. S.J. Shankland P.A. Hamel J.W. Scholey Cyclin and cyclin dependent kinase expression in the remnant glomerulus J Am Soc Nephrol 8 1997 368 375
146. S.K. Park S.K. Kang D.Y. Lee M.J. Kang S.H. Kim G.Y. Koh Alterations of cyclin and cyclin-dependent kinases during renal development and pathologic growth J Am Soc Nephrol 6 1995 114 (abstract)
147. Y. Terada A. Shimizu S. Sasaki N. Yamanaka F. Marumo Regulations of G1 cyclin and cell cycle inhibitors during recovery from acute renal ischemia J Am Soc Nephrol 6 1995 992 (abstract)
148. S.K. Park M.J. Kang I. Kim A. Terhune G.Y. Koh Temporal expression of cyclin dependent kinase inhibitors during renal development and hypertrophic renal growth J Am Soc Nephrol 7 1996 1663 (abstract)
149. P.M. Price J. Megyesi N. Udvarhelyi R. Safirstein Synthesis of mRNA for the p21, a protein associated with cell-cycle arrest, senescence and terminal differentiation following acute renal failure J Am Soc Nephrol 6 1995 114 (abstract)
150. J.J. Morrissey S. Ishidoya R. Mccracken S. Klahr The effect of ACE inhibitors on the expression of matrix genes and the role of p53 and p21 (WAF1) in experimental renal fibrosis Kidney Int 49 Suppl 54 1996 S83 S87
151. S.J. Shankland C.H. Hugo S.R. Coats M. Nangaku K.L. Gordon J. Pippin J.M. Roberts W.G. Couser R.J. Johnson Cyclin kinase inhibitors: Potential regulators of mesangial cell (MC) proliferation in vivo J Am Soc Nephrol 6 1995 776 (abstract)
152. Y. Terada T. Yamada S. Sasaki F. Marumo Overexpression of cyclin D1 and cell cycle inhibitors (p16INK4 and p21cip1) using adenovirus vectors regulates proliferation in rat mesangial cells J Am Soc Nephrol 8 1997 51 60
153. H.O. Schoecklmann H.D. Rupprecht I. Zauner R.B. Sterzel TGF- β 1 induced cell cycle arrest in renal mesangial cells involves inhibition of cyclin E-CDK2 activation and retinoblastoma protein phosphorylation Kidney Int 51 1997 1228 1236
154. Kip1 Kidney Int 51 1997 1088 1099
155. H. Huang H. Wang Cyclin D1, Cdk4 expression and cyclin D1 upregulation by endothelin-1 in rat mesangial cells J Am Soc Nephrol 7 1996 1658 (abstract)
156. S. Inoshita Y. Terada T. Ymamda O. Nakashima S. Sasaki F. Marumo Mitogenic signaling of endothelin-1 is regulated by cyclin D1, p16 and the phosphorylation of retinoblastoma gene product in rat mesangial cells J Am Soc Nephrol 7 1996 1564 (abstract)
157. Y. Terada T. Yamada O. Nakashima S. Sasaki F. Marumo TGF- β and simvastatin inhibit rat mesangial cell proliferation via different CDK inhibitor in vitro and in anti-Thyl nephritis J Am Soc Nephrol 7 1996 1722 (abstract)
158. R. Pabst R.B. Sterzel Cell renewal of glomerular cell types in normal rats. An autoradiographic analysis Kidney Int 24 1983 626 631
159. R.J. Johnson P. Pritzl H. Iada C.E. Alpers Platelet-complement interactions in mesangial proliferative nephritis in the rat Am J Pathol 138 1991 313 321
160. J. Floege E. Eng B.A. Young C.E. Alpers T.B. Barrett D.F. Bowen-Pope R.J. Johnson Infusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats J Clin Invest 92 1993 2952 2962
161. S.J. Shankland P.A. Hamel J.W. Scholey Phosphorylation of reti noblastoma protein in glomeruli of normal, diabetic and renal-ablated rats J Am Soc Nephrol 5 1994 701 (abstract)
162. T. Yamada Y. Terada A. Shimizu Sasaki N. Yamanaka F. Murumo Regulations of G1 cyclin and cell cycle inhibitors during recovery from acute renal ischemia J Am Soc Nephrol 6 1995 992 (abstract)
163. H.A. Franch J.W. Shay R.J. Alpern P.A. Preisig Involvement of pRb family in TGF β -dependent epithelial cell hypertrophy J Cell Biol 129 1995 245 254
164. H.A. Franch R.J. Alpern P.A. Preisig TGF β converts EGF-induced hyperplasia to hypertrophy by inhibiting CDK2/cyclin E kinase activity J Am Soc Nephrol 6 1995 767 (abstract)
165. M. Yoshizumi W.-S. Lee C.-M. Hsieh J.-C. Tsai J. Li M.A. Perrella C. Patterson W.O. Endege R. Schegel M.-E. Lee Disappearance of cyclin A correlates with permanent withdrawal of cardiomyocytes from the cell cycle in human and rat hearts J Clin Invest 95 1995 2275 2280
166. T. Yamamoto N.A. Noble D.E. Miller W.A. Border Sustained expression of TGF- β 1 underlies development of progressive kidney fibrosis Kidney Int 45 1994 916 927
167. P.M. Price J. Megyesi N. Udvarhelyi R. Safirstein Induction of terminal differentiation in kidney tubules by the p21 cyclin dependent kinase (CDK) inhibitor J Am Soc Nephrol 7 1996 1603 (abstract)
168. M. Nagata Y. Yamaguchi K. Ito LOSS of mitotic activity and the expression of vimentin in glomerular epithelial cells of developing human kidneys Anat Embryol 187 1993 275 279
169. J. Floege W. Kriz M. Schulze M. Susani D. Kerjaschki A. Mooney W.G. Couser K.M. Koch Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephrology J Clin Invest 96 1996 2809 2819
170. S.J. Shankland J. Pippin R.H. Pichler K.L. Gordon S. Friedman L.I. Gold R.J. Johnson W.G. Couser Differential expression of transforming growth factor- β isoforms and receptors in experimental membranous nephropathy Kidney Int 50 1996 116 124
171. S. Adler X. Chen B. Eng Control of rat glomerular epithelial cell growth in vitro Kidney Int 37 1990 1048 1054
172. W.A. Border N.A. Noble Transforming growth factor 18 in tissue fibrosis N Engl J Med 331 1994 1286 1292
173. K. Sharma F.N. Ziyadeh The emerging role of transforming growth factor- β in kidney diseases Am J Physiol 266 1994 F829 F842
174. M.E. Choi K. Eung-Gook Q. Huang B.J. Ballerman Rat mesangial cell hypertrophy in response to transforming growth factor-131 Kidney Int 44 1993 948 958
175. P.A. Preisig H.A. Franch Renal epithelial hyperplasia and hyper trophy Semin Nephrol 15 1995 327 340
176. B. Liu P.A. Preisig TGF β -mediated conversion of EGF-induced hyperplasia to hypertrophy involves cyclin E, but not cyclin D kinase regulation, and is dependent on cells being in a confluent state J Am Soc Nephrol 7 1996 1661 (abstract)
177. Y. Terada T. Yamada O. Nakashima S. Sasaki F. Marumo Angiotensin II induced p21CIP1 via JAK2-STAT1 pathway and caused hypertrophy in proximal tubule cells J Am Soc Nephrol 7 1996 1776 (abstract)
178. G. Wolf R.A.K. Stahl Angiotensin II (All) stimulated hypertrophy of LLC-PK1 cells depends on the induction of the cyclin-dependent kinase inhibitor p27Kip1 Kidney Int 50 1996 2112 2119
179. K. Sharma Y. Jin J. Guo F.N. Ziyadeh Neutralization of TGF- β by anti-TGF- β antibody attenuates kidney hypertrophy and enhanced extracellular mtrix gene expression in STZ-induced diabetic mice Diabetes 45 1996 522 530
180. S.J. Shankland J.W. Scholey Expression of transforming growth factor- β 1 during diabetic renal hypertrophy Kidney Int 46 1994 430 442
181. WAF1/CIP1/SDT1 after acute renal failure Am J Physiol 271 1996 F1211 F1216